[1]
|
M. Stefanov, “Extraglandular and Intraglandular Vascularization of Canine Prostate,” Microscopy Research and Technique, Vol. 64, No. 3, 2004, pp. 188-197.
|
[2]
|
E. Bigliardi and L. Ferrari, “Contrast-Enhanced Ultrasound of the Normal Canine Prostate Gland,” Veterinary Radiology Ultrasound, Vol. 52, No. 1, 2011, pp. 107-110.
|
[3]
|
E. Teske, E. C. Naan, E. M. Van Dijk, E. Van Garderen and J. A. Schalken, “Canine Prostate Carcinoma: Epidemiological Evidence of an Increased risk in Castrated Dogs,” Molecular and Cellular Endocrinology, Vol. 197, No. 1-2, 2002, pp. 251-255.
doi:10.1016/S0303-7207(02)00261-7
|
[4]
|
B. E. LeRoy and N. Northrup, “Prostate Cancer in Dogs: Comparative and Clinical Aspects,” The Veterinary Journal, Vol. 180, No. 2, 2009, pp. 149-162.
doi:10.1016/j.tvjl.2008.07.012
|
[5]
|
K. K. Cornell, D. G. Bostwick, D. M. Cooley, G. Hall, H. J. Harvey, M. J. Hendrick, B. U. Pauli, J. A. Render, G. Stoica, D. C.Sweet and D. J. Waters, “Clinical and Pathologic Aspects of Spontaneous Canine Prostate Carcinoma: A Retrospective: An Aalysis of 76 Cases,” The Prostate, Vol. 45, No. 2, 2000, pp. 173-183.
doi:10.1002/1097-0045(20001001)45:2<173::AID-PROS12>3.0.CO;2-R
|
[6]
|
F. W. Bell, J. S. Klausner, D. W. Hayden, D. A. Feeney and S. D. Johnston, “Clinical and Pathological Features of Prostatic Adenocarcinoma in Sexually Intact and Castrated Dogs: 31 Cases (1970-1987),” Journal of the American Veterinary Medical Association, Vol. 199, No. 11, 1991, pp. 623-630.
|
[7]
|
A. Maini, C. Archer, C. Y. Wang and G. P. Haas, “Comparative Pathology of Bening Prostatic Hyperplasia and Prostate Cancer,” In Vivo, Vol. 11, No. 4, 1997, pp. 293-300.
|
[8]
|
W. Mahapokai, Y. Xue, E. van Garderen, F. J. van Sluijs, J. A. Mol and J. A. Schalken, “Cell Kinetics and Differentiation after Hormonal-Induced Prostatic Hyperplasia in the Dog,” Prostate, Vol. 44, No. 1, 2000, pp. 40-48.
doi:10.1002/1097-0045(20000615)44:1<40::AID-PROS6>3.0.CO;2-J
|
[9]
|
A. R. Gunzel-Apel, C. Moehrke and C. P. Nautrup, “Colour-Codex and Pulsed Doppler Sonography of Canine Testis, Epididymis and Prostate Gland: Physiological and Pathological Findings,” Reproduction in Domestic Animals, Vol. 36, No. 5, 2001, pp. 236-240.
doi:10.1046/j.1439-0531.2001.00288.x
|
[10]
|
K. U. Sorenmo, M. Goldschmidt, F. Shofer, C. Goldkamp and J. Ferracone, “Immunohistochemical Characterization of Canine Prostatic Carcinoma and Correlation with Castration Status and Castration time,” Veterinary and Comparative Oncology, Vol. 1, No. 1, 2003, pp. 48-56.
doi:10.1046/j.1476-5829.2003.00007.x
|
[11]
|
F. R. Shidaifat, M. Daradka and R. Al Omari, “Effect of Androgen Ablation on Prostatic Cell Differentiation in Dogs,” Endocrine Research, Vol. 30, No. 3, 2004, pp. 327-334. doi:10.1081/ERC-200033196
|
[12]
|
K. U. Sorenmo, M. Goldschmidt, F. Shofer, C. Goldkamp and J. Ferracone, “Evaluation of Cyclooxigenase-1 and Cyclooxygenase-2 Expression and the Effect of Cycloxygenase Inhibitors in Canine Prostatic Carcinoma,” Veterinary and Comparative Oncology, Vol. 2, No. 1, 2004, pp. 13-23.
|
[13]
|
J. J. Arthur, M. M. Kleiter, D. E. Thrall and A. F. Pruitt, “Characterization of Normal Tissue Complications in 51 Dogs Undergoing Definitive Pelvic Region Irradiation,” Veterinary Radiology and Ultrasound, Vol. 49, No. 1, 2008, pp. 85-89. doi:10.1111/j.1740-8261.2007.00322.x
|